Fonar ROA 2006-2019 | FONR

Current and historical return on assets (ROA) values for Fonar (FONR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Fonar ROA for the three months ending September 30, 2019 was 10.44%.
Fonar ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-09-30 $0.01B $0.17B 10.16%
2019-06-30 $0.01B $0.13B 11.11%
2019-03-31 $0.02B $0.13B 15.57%
2018-12-31 $0.02B $0.12B 15.38%
2018-09-30 $0.02B $0.12B 16.89%
2018-06-30 $0.02B $0.12B 17.63%
2018-03-31 $0.02B $0.11B 15.53%
2017-12-31 $0.02B $0.11B 19.14%
2017-09-30 $0.02B $0.10B 20.00%
2017-06-30 $0.02B $0.10B 20.82%
2017-03-31 $0.02B $0.09B 21.65%
2016-12-31 $0.02B $0.09B 18.77%
2016-09-30 $0.02B $0.09B 18.02%
2016-06-30 $0.02B $0.09B 18.40%
2016-03-31 $0.01B $0.08B 17.67%
2015-12-31 $0.01B $0.08B 16.77%
2015-09-30 $0.01B $0.08B 15.53%
2015-06-30 $0.01B $0.08B 14.24%
2015-03-31 $0.01B $0.08B 12.90%
2014-12-31 $0.01B $0.08B 12.86%
2014-09-30 $0.01B $0.08B 12.94%
2014-06-30 $0.01B $0.08B 13.07%
2014-03-31 $0.01B $0.08B 13.25%
2013-12-31 $0.01B $0.08B 12.04%
2013-09-30 $0.01B $0.08B 12.36%
2013-06-30 $0.01B $0.07B 12.84%
2013-03-31 $0.00B $0.07B 8.94%
2012-12-31 $0.00B $0.04B 11.35%
2012-09-30 $0.00B $0.04B 11.68%
2012-06-30 $0.00B $0.03B 11.85%
2012-03-31 $0.00B $0.04B 9.02%
2011-12-31 $0.00B $0.03B 9.68%
2011-09-30 $0.00B $0.03B 10.43%
2011-06-30 $0.00B $0.03B 7.69%
2011-03-31 $0.00B $0.03B 8.51%
2010-12-31 $0.00B $0.02B 4.40%
2010-09-30 $-0.00B $0.02B -4.35%
2010-06-30 $-0.00B $0.02B -12.37%
2010-03-31 $-0.00B $0.02B -11.65%
2009-12-31 $-0.00B $0.03B -7.27%
2009-09-30 $0.00B $0.03B 0.00%
2009-06-30 $0.00B $0.03B 6.45%
2009-03-31 $-0.01B $0.03B -15.27%
2008-12-31 $-0.01B $0.03B -25.35%
2008-09-30 $-0.01B $0.03B -37.33%
2008-06-30 $-0.01B $0.04B -35.22%
2008-03-31 $-0.02B $0.04B -38.79%
2007-12-31 $-0.02B $0.04B -41.86%
2007-09-30 $-0.02B $0.04B -41.30%
2007-06-30 $-0.03B $0.04B -51.02%
2007-03-31 $-0.03B $0.05B -47.17%
2006-12-31 $-0.03B $0.05B -47.79%
2006-09-30 $-0.03B $0.05B -44.63%
2006-06-30 $-0.03B $0.06B -44.96%
2006-03-31 $-0.02B $0.06B -28.88%
2005-12-31 $-0.01B $0.07B -17.93%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.134B $0.087B
FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $159.545B 22.04
Abbott Laboratories (ABT) United States $157.393B 28.71
Stryker (SYK) United States $79.374B 26.69
Boston Scientific (BSX) United States $61.719B 29.13
Baxter (BAX) United States $45.812B 27.78
Essilor Luxottica (ESLOY) France $35.128B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.725B 19.27
Lonza Group Ag (LZAGY) Switzerland $28.134B 0.00
Coloplast (CLPBY) Denmark $27.648B 42.67
Terumo (TRUMY) Japan $26.986B 0.00
ResMed (RMD) United States $23.088B 42.59
Smith & Nephew SNATS (SNN) United Kingdom $21.557B 0.00
Sunny Optical Technology (SNPTF) China $20.017B 0.00
Insulet (PODD) United States $11.669B 555.18
Bio-Rad Laboratories (BIO) United States $11.282B 54.15
Canopy Growth (CGC) Canada $8.676B 0.00
Perrigo (PRGO) Ireland $8.033B 14.98
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Hill-Rom Holdings (HRC) United States $7.750B 22.78
DiaSorin S.p.A (DSRLF) Italy $7.357B 0.00
GN STORE NORD (GNNDY) Denmark $6.158B 0.00
Haemonetics (HAE) United States $5.770B 38.99
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
NuVasive (NUVA) United States $4.065B 32.01
ICU Medical (ICUI) United States $3.960B 25.81
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.923B 0.00
Neogen (NEOG) United States $3.757B 62.53
GW Pharmaceuticals (GWPH) United Kingdom $3.675B 0.00
Agios Pharmaceuticals (AGIO) United States $3.113B 0.00
Quidel (QDEL) United States $3.020B 28.66
National Vision Holdings (EYE) United States $2.597B 58.63
Aurora Cannabis (ACB) Canada $2.321B 0.00
Cardiovascular Systems (CSII) United States $1.887B 0.00
AtriCure (ATRC) United States $1.513B 0.00
InMode (INMD) Israel $1.440B 0.00
TG Therapeutics (TGTX) United States $1.364B 0.00
Aphria (APHA) $1.331B 0.00
VAREX IMAGING (VREX) United States $1.206B 24.09
NanoString Technologies (NSTG) United States $1.101B 0.00
Phibro Animal Health (PAHC) United States $1.043B 19.54
PetIQ (PETQ) United States $0.869B 21.20
Eagle Pharmaceuticals (EGRX) United States $0.806B 30.87
Lantheus Holdings (LNTH) United States $0.742B 18.54
LeMaitre Vascular (LMAT) United States $0.737B 41.43
Omeros (OMER) United States $0.678B 0.00
Quanterix (QTRX) United States $0.675B 0.00
Cerus (CERS) United States $0.571B 0.00
Surmodics (SRDX) United States $0.560B 58.06
MacroGenics (MGNX) United States $0.551B 0.00
Organigram Holdings (OGI) Canada $0.509B 0.00
OraSure Technologies (OSUR) United States $0.507B 30.44
HEXO (HEXO) $0.441B 0.00
Meridian Bioscience (VIVO) United States $0.424B 14.54
Utah Medical Products (UTMD) United States $0.392B 28.37
Zynex (ZYXI) United States $0.350B 39.59
Owens & Minor (OMI) United States $0.346B 12.81
BioLife Solutions (BLFS) United States $0.332B 135.08
Neptune Wellness Solutions (NEPT) Canada $0.285B 0.00
Bovie Medical (APYX) United States $0.277B 0.00
Female Health (VERU) United States $0.273B 0.00
Vapotherm (VAPO) United States $0.259B 0.00
United Health Products (UEEC) United States $0.233B 0.00
Repro-Med Systems (KRMD) United States $0.225B 0.00
Viemed Healthcare (VMD) United States $0.209B 22.04
Green Organic Dutchman Holdings (TGODF) Canada $0.178B 0.00
Liberty Health Sciences (LHSIF) Canada $0.177B 0.00
Rockwell Medical (RMTI) United States $0.166B 0.00
Cytosorbents (CTSO) United States $0.149B 0.00
Chimerix (CMRX) United States $0.125B 0.00
MTech Acquisition (KERN) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.095B 0.00
Surface Oncology (SURF) United States $0.094B 0.00
United-Guardian (UG) United States $0.089B 22.57
MRI Interventions (MRIC) United States $0.086B 0.00
Nephros (NEPH) United States $0.074B 0.00
Chembio Diagnostics (CEMI) United States $0.069B 0.00
FSD PHARMA INC (HUGE) $0.051B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.025B 0.00
GUARDION HEALTH (GHSI) United States $0.023B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Senestech (SNES) United States $0.016B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00